Clinical Trial Update: Abemaciclib in Combination With Bicalutamide for Androgen Receptor-positive, HER2-negative Metastatic Breast Cancer [Phase 1, Phase 2]

View source ↗

Summary

This entry reports a planned Phase 1/Phase 2 clinical trial evaluating abemaciclib in combination with bicalutamide for androgen receptor-positive, HER2-negativ…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Casodex (bicalutamide)
• VERZENIO (ABEMACICLIB)

Snippet

Sponsor: Icahn School of Medicine at Mount Sinai | Conditions: Breast Cancer, Metastasis | Phase 1, Phase 2 | Status: RECRUITING